NAVB
Renaissance Technologies’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-238,133
| Closed | -$62K | – | 4458 |
|
|
2023
Q1 | $62K | Buy |
238,133
+172,800
| +264% | +$45K | ﹤0.01% | 3612 |
|
|
2022
Q4 | $14K | Buy |
65,333
+39,500
| +153% | +$8.46K | ﹤0.01% | 4017 |
|
|
2022
Q3 | $7K | Buy |
25,833
+13,200
| +104% | +$3.58K | ﹤0.01% | 3965 |
|
|
2022
Q2 | $9K | Buy |
+12,633
| New | +$9K | ﹤0.01% | 4165 |
|
|
2021
Q2 | – | Sell |
-131,618
| Closed | -$266K | – | 3948 |
|
|
2021
Q1 | $266K | Buy |
131,618
+75,923
| +136% | +$153K | ﹤0.01% | 3088 |
|
|
2020
Q4 | $120K | Sell |
55,695
-40,453
| -42% | -$87.2K | ﹤0.01% | 3236 |
|
|
2020
Q3 | $260K | Sell |
96,148
-152,852
| -61% | -$413K | ﹤0.01% | 3043 |
|
|
2020
Q2 | $981K | Buy |
+249,000
| New | +$981K | ﹤0.01% | 2547 |
|
|
2016
Q1 | – | Sell |
-606,600
| Closed | -$807K | – | 3625 |
|
|
2015
Q4 | $807K | Buy |
606,600
+167,600
| +38% | +$223K | ﹤0.01% | 2558 |
|
|
2015
Q3 | $1M | Buy |
+439,000
| New | +$1M | ﹤0.01% | 2383 |
|
|
2015
Q2 | – | Sell |
-15,500
| Closed | -$25K | – | 3475 |
|
|
2015
Q1 | $25K | Buy |
+15,500
| New | +$25K | ﹤0.01% | 3112 |
|